Europe’s biomedical researchers prepare to gather in Belgium
A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
ENCITE is a collaborative project coordinated by EIBIR. It is related to the theme “Cooperation health: in vivo image-guidance for cell therapy,” and is supported by the European Commission within the 7th Framework Programme for Research. It started in June 2009, thanks to a financial contribution of €12 million. ENCITE is a four-year project and has 29 project partners from 11 countries with expertise in the field of cell imaging.
The mission of the project is to develop and test new MR and optical imaging methods and biomarkers to get a more comprehensive picture of cell fate and reactions of the immune system, and ultimately to improve and further develop cell therapy for the benefit of the European patient. Details on the interim results can be found here.
The deadline to register is April 20.
For more information, please contact: office@eibir.org.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
